References
- Rosen LS, Gordon D, Kaminski M, et al. Zoledronic acid versus pamidronate in the treatment of skeletal metas-tases in patients with breast cancer or osteolytic lesions of multiple myeloma: a phase III, double-blind, comparative trial. Cancer J 2001; 7: 377–387.
- Saad F, Gleason DM, Murray R, et al., and the Zoledronic Acid Prostate Cancer Study Group. A randomized, placebo-controlled trial of zoledronic acid in patients with hor-mone-refractory metastatic prostate carcinoma. J Nati Cancer Inst 2002; 94: 1458–1468.
- Rosen LS, Gordon D, Tchekmedyian S, et al. Zoledronic acid versus placebo in the treatment of skeletal metastases in patients with lung cancer and other solid tumors: a phase III, double-blind, randomized trial-the Zoledronic Acid Lung Cancer and Other Solid Tumors Study Group. J Clin Oncol 2003; 21: 3150–3157.
- Twycross R, Lack S. Therapeutics in terminal cancer. London: Churchill Livingstone; 1990.
- Aaronson NK, Ahmedzai S, Bergman B. The European Organisation for Research andTreatment of Cancer QLQ-C30: a quality of life instru-ment for use in international clinical trials in oncology. J Nati Cancer Inst 1993; 85: 365–376.
- Wiggers JH, Donovan KO, Redman S. Cancer patient satisfaction with care. Cancer 1990; 66: 610–616.
- Creel J. Cancer care at home: past, present, and future. Caring 1996; 15: 24-6, 29.
- Dougherty L, Viner C, Young J. Establishing ambulato-ry chemotherapy at home. Prof Nurse. 1998; 13: 356–8.
- National Home and Hospice Care Survey, 2000. National Center for Health Statistics. http://www.cdc.gov/nchs/data/nhhcsd/curhomecare00.pdf
- Vokes EE, Schilsky RL, Choi KE, et al. A randomized study of inpatient versus outpatient continuous infusion chemotherapy for patients with locally advanced head and neck cancer. Cancer. 1989; 63: 30–6.
- Spatti G, Regazzoni M, Koronel R, Zecchini AM, De Palo G. Adjuvant treatment with melphalan in ovarian carcino-ma with no residual disease following surgery. Tumori. 1987; 73: 157–62.
- Falcone A, Pfanner E, Ricci S, et al. Oral doxifluridine in elderly patients with metastatic colorectal cancer: a multi-center phase II study. Ann Oncol. 1994; 5: 760–2.
- Atzpodien J, Korfer A, Franks CR, Poliwoda H, Kirchner H. Home therapy with recombinant interleukin-2 and interferon-alpha 2b in advanced human malignancies. Lancet. 1990; 335: 1509-12.
- Collichio FA, Amamoo MA, Fogleman J, Griggs J, Graham M. Phase II study of low-dose infusional 5-fluorouracil and paclitaxel (Taxol) given every 2 weeks in metastatic breast cancer. Am J Clin Oncol. 2002 Apr; 25 (2): 194–7.
- Borner MM, Schoffski P, de Wit R, et al. Patient pref-erence and pharmacokinetics of oral modulated UFT versus intravenous fluorouracil and leucovorin: a randomised crossover trial in advanced colorectal cancer. Eur J Cancer 2002; 38: 349–58.
- Holdsworth MT, Raisch DW, Chavez CM, Duncan MH, Parasuraman TV, Cox FM. Economic impact with home delivery of chemotherapy to pediatric oncology patients. Ann Pharmacother 1997; 31 (2): 140–8.
- Close P, Burkey E, Kazak A, Danz P, Lange B. A prospective, controlled evaluation of home chemotherapy for children with cancer. Pediatrics 1995; 95 (6): 896–900.